Search clinical trials for: Irinotecan and cisplatin after chemoradiotherapy

Total 5607 results

Emory University
Ipsen; Taiho Oncology, Inc.

Recruiting

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Gastric Adenocarcinoma | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Colorectal Adenocarcinoma | Stage IV Gastric Cancer | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Stage... and other conditions

United States
Henan Cancer Hospital
Rongchang Biopharmaceutical; Zhengda Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer

HER2-positive Gastric Cancer | Advanced Gastric Carcinoma

China
University of Vermont
Johnson & Johnson

Recruiting

Intratumoral Cisplatin for Resectable NSCLC

Non-Small Cell Lung Cancer

United States
Korea Cancer Center Hospital

Withdrawn

Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients

Cervical Neoplasms

Korea, Republic of
Sun Yat-sen University

Unknown

Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC (TIL)

Nasopharyngeal Carcinoma

China
National Cancer Institute (NCI)

Completed

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Pomeranian Medical University Szczecin
Maria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology...

Unknown

Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

BRCA1 Mutation | Breast Cancer Invasive Nos

Poland
Alberta Health services
Amersham Health; The Prostate Cancer Research Foundation of Canada

Completed

A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

Bone Metastases | Hormone Refractory Prostate Cancer

Canada
National Cancer Institute (NCI)

Completed

Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis

Stomach Neoplasms | Peritoneal Neoplasms

United States
Fudan University

Not yet recruiting

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Colorectal Cancer | Liver Metastases

China
Mayo Clinic

Active, not recruiting

Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

Oropharynx Cancer

United States
Anna Olczak

Completed

The Use of the Tip Stim Glove Device to Achieve Coordinated Movement of the Human Hand

Stroke, Ischemic

Poland
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer

Esophageal Cancer

France
Raban Jeger

Recruiting

Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study (ALFA ROMEO)

Atrial Fibrillation | Foramen Ovale, Patent | Cryptogenic Stroke

Switzerland
Assistance Publique - Hôpitaux de Paris

Recruiting

Observational Database on Deep Brain Stimulation in Tourette Syndrome (POSTSTIC)

Tourette Syndrome

France
Schulthess Klinik

Recruiting

Bursa Augmentation in Arthroscopic Rotator Cuff Repair (ARCR-Bursa)

Rotator Cuff Tear or Rupture, Not Specified as Traumatic

Switzerland
Suleyman Demirel University

Completed

The Effect of Mobile Application-based Information About Before and After Surgery

Breast Cancer

Turkey
Norwegian University of Science and Technology
Oslo University Hospital; St. Olavs Hospital; LHL-Klinikkene, Røros

Completed

Rehabilitation for Head and Neck Cancer

Head and Neck Neoplasms

Norway
University of Victoria

Unknown

Can Arm and Leg Cycling Exercise Improve Walking After Stroke

Cerebrovascular Accident

Canada
University Hospital, Ghent

Completed

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer (OvIP1)

Ovarian Cancer | Primary Peritoneal Cancer

Belgium
Guangdong Association of Clinical Trials

Unknown

Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment

Small Cell Lung Cancer

China
National Cancer Center, Korea

Unknown

Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan

Colorectal Neoplasms | Secondary

Korea, Republic of
University Hospital, Rouen

Completed

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Esophageal Neoplasms

France
Duke University
Pfizer

Completed

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

Glioblastoma

United States
Chang Gung Memorial Hospital
National Science and Technology Council

Recruiting

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

Lung Cancer | Relapse/Recurrence

Taiwan
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy (IMMUVIX)

Cervical Cancer

France
Taiho Oncology, Inc.

Completed

Evaluating Patients With Varying Degrees of Renal Function

Renal Impairment

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck

Head and Neck Cancer

United States
Korea Cancer Center Hospital

Completed

Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer

CERVICAL NEOPLASMS

Korea, Republic of
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva

Vulvar Cancer

United States, Canada
Taiho Oncology, Inc.

Completed

Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

Gastric Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
US Oncology Research
Bristol-Myers Squibb; Pfizer

Active, not recruiting

PhII ICb With/Without Erbitux in MBC Pts (CA225200)

Metastatic Breast Cancer

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV

Non Small Cell Lung Cancer

Greece
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer

Breast Cancer

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Aging Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Cancer Advances Inc.

Completed

Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma (CC6)

Colorectal Cancer
Texas Children's Cancer Center

Completed

Irinotecan in Treating Children With Refractory or Progressive Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
Northwestern University
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer

Breast Cancer

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

Breast Cancer

United States
University Health Network, Toronto
Princess Margaret Hospital, Canada

Terminated

Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer (OVHM-01)

Epithelial Ovarian Cancer

Canada
University of Zurich
Swiss National Science Foundation; Swiss Accident Insurance Fund SUVA

Completed

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States, Canada
TTY Biopharm

Completed

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Non-small-cell Lung Cancer (NSCLC)

Taiwan
International Atomic Energy Agency

Completed

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Cervix Cancer

Peru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
Taiho Oncology, Inc.

Completed

Evaluating Patients With Impaired Hepatic Function

Impaired Hepatic Function

United States
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion (CisFRad)

Squamous Cell Carcinoma of the Head and Neck

France
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina

Search clinical trials for: Irinotecan and cisplatin after chemoradiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations